The present invention relates various compositions having an immunostimulatory molecule and animal cells cultured in the presence of at least one interferon (IFN) of type I or type II for time and conditions sufficient to enhance the antigen presenting function of the cells. Other aspects of the present invention include methods of treatment and/or prophylaxis of a disease or condition using these immunopotentiating compositions.